Financial Strength
by Company within Biotechnology & Pharmaceuticals Industry
|
Company |
Quarter |
Sales/Employee
(TTM) |
Debt to Equity |
Quick Ratio |
Leverage Ratio |
Amgen Inc |
2 Q |
$ 1,098,430 |
9.08 |
2 |
11.94 |
Gilead Sciences Inc |
2 Q |
$ 1,901,528 |
1.2 |
0.07 |
1.79 |
Biogen Inc |
2 Q |
$ 1,037,617 |
0.43 |
1.09 |
0.74 |
Qiagen N v |
4 Q |
$ 523,750 |
0.27 |
0.7 |
0.4 |
Halozyme Therapeutics Inc |
2 Q |
$ 256,942 |
9.91 |
1.9 |
10.99 |
Bio techne Corp |
2 Q |
$ 378,605 |
0.18 |
1.59 |
0.24 |
Moderna Inc |
2 Q |
$ 3,945,926 |
- |
2.71 |
0.29 |
Seagen Inc |
2 Q |
$ 800,741 |
- |
1.69 |
0.29 |
Biontech Se |
4 Q |
$ 317,767 |
- |
4.7 |
0.16 |
Repligen Corp |
2 Q |
$ 623,361 |
0.14 |
1.62 |
0.29 |
Neurocrine Biosciences Inc |
2 Q |
$ 1,673,000 |
0.09 |
1.68 |
0.41 |
Twist Bioscience Corporation |
2 Q |
$ 313,960 |
- |
4.9 |
0.23 |
Nanostring Technologies Inc |
2 Q |
$ 199,619 |
- |
1.84 |
- |
Coherus Biosciences inc |
2 Q |
$ 279,889 |
- |
0.85 |
- |
Adaptive Biotechnologies Corporation |
2 Q |
$ 293,955 |
- |
4.38 |
0.93 |
Exelixis Inc |
2 Q |
$ 3,028,783 |
- |
3.73 |
0.24 |
Valneva Se |
4 Q |
$ 708,830 |
0.4 |
1.04 |
1.83 |
Acceleron Pharma inc |
3 Q |
$ 250,584 |
- |
10.29 |
0.02 |
Ginkgo Bioworks Holdings Inc |
2 Q |
$ 777,931 |
- |
6.77 |
0.52 |
Sangamo Therapeutics Inc |
2 Q |
$ 531,586 |
- |
2.66 |
0.39 |
Novavax inc |
2 Q |
$ 4,317,170 |
- |
0.32 |
- |
Denali Therapeutics Inc |
4 Q |
$ 319,009 |
- |
3.67 |
0.4 |
Acorda Therapeutics Inc |
2 Q |
$ 357,535 |
2.6 |
0.83 |
3.02 |
Regenxbio Inc |
2 Q |
$ 323,240 |
- |
2.72 |
0.68 |
Aerie Pharmaceuticals Inc |
3 Q |
$ 826,027 |
- |
1.29 |
- |
Adma Biologics Inc |
2 Q |
$ 811,231 |
0.96 |
1.49 |
1.33 |
Fate Therapeutics Inc |
2 Q |
$ 573,317 |
- |
1.05 |
0.1 |
Genfit S a |
4 Q |
$ 153,371 |
- |
3.45 |
0.42 |
Biocryst Pharmaceuticals Inc |
2 Q |
$ 1,597,089 |
- |
4.41 |
- |
Alector Inc |
2 Q |
$ 658,419 |
- |
4.76 |
2.61 |
Jounce Therapeutics inc |
4 Q |
$ 1,182,976 |
- |
8.04 |
0.16 |
Iteos Therapeutics Inc |
2 Q |
$ 1,316,526 |
- |
13.49 |
0.13 |
Dyadic International Inc |
2 Q |
- |
- |
5.06 |
0.23 |
Cullinan Oncology Inc |
2 Q |
- |
- |
24.99 |
0.04 |
Zivo Bioscience Inc |
2 Q |
- |
- |
0.01 |
- |
Passage Bio inc |
2 Q |
- |
- |
7.62 |
0.29 |
Replimune Group Inc |
2 Q |
- |
0.06 |
16.72 |
0.17 |
Immunitybio inc |
2 Q |
- |
- |
0.07 |
- |
Tarsus Pharmaceuticals Inc |
2 Q |
- |
0.17 |
4.84 |
0.28 |
Aligos Therapeutics Inc |
2 Q |
- |
- |
3.34 |
0.52 |
Kiromic Biopharma Inc |
2 Q |
- |
- |
0.14 |
- |
Taysha Gene Therapies Inc |
2 Q |
- |
- |
0.89 |
- |
Inhibrx Inc |
2 Q |
- |
- |
6.14 |
- |
Omega Therapeutics Inc |
2 Q |
- |
0.21 |
3.36 |
1.39 |
Athira Pharma Inc |
2 Q |
- |
- |
8.59 |
0.12 |
Allovir Inc |
2 Q |
- |
- |
8.07 |
0.23 |
C4 Therapeutics Inc |
2 Q |
- |
0.04 |
0.93 |
0.6 |
Checkmate Pharmaceuticals Inc |
1 Q |
- |
- |
5.03 |
- |
Precision Biosciences Inc |
2 Q |
- |
0.66 |
2.44 |
4.34 |
Orchard Therapeutics Plc |
2 Q |
- |
0.26 |
2.62 |
1.13 |
Kaleido Biosciences Inc |
4 Q |
- |
1.52 |
1.3 |
1.93 |
Dbv Technologies S a |
2 Q |
- |
- |
5.21 |
0.32 |
Scholar Rock Holding Corp |
2 Q |
- |
0.25 |
10.25 |
0.33 |
Erytech Pharma S a |
4 Q |
- |
0.32 |
3.32 |
0.52 |
Inmune Bio Inc |
2 Q |
- |
0.2 |
3.66 |
0.46 |
Replicel Life Sciences Inc |
4 Q |
- |
- |
0.22 |
- |
Cellectis S a |
4 Q |
- |
- |
3.76 |
0.4 |
Polarityte Inc |
4 Q |
- |
- |
5.54 |
0.37 |
X4 Pharmaceuticals Inc |
2 Q |
- |
0.01 |
6.35 |
1.55 |
Biondvax Pharmaceuticals Ltd |
4 Q |
- |
- |
6.02 |
- |
Vaxart Inc |
2 Q |
- |
- |
1.77 |
0.44 |
Inhibikase Therapeutics Inc |
2 Q |
- |
0.02 |
7.66 |
0.15 |
Poseida Therapeutics Inc |
2 Q |
- |
0.43 |
4.3 |
0.88 |
Lineage Cell Therapeutics Inc |
2 Q |
- |
- |
2.86 |
0.57 |
Relay Therapeutics Inc |
2 Q |
- |
- |
2.04 |
0.19 |
Ocugen Inc |
2 Q |
- |
0.04 |
5.24 |
0.22 |
Beam Therapeutics Inc |
2 Q |
- |
- |
5.12 |
0.67 |
Creative Medical Technology Holdings Inc |
2 Q |
- |
- |
34.05 |
0.03 |
Black Diamond Therapeutics Inc |
2 Q |
- |
- |
6.44 |
0.46 |
Protara Therapeutics Inc |
2 Q |
- |
- |
16.29 |
0.12 |
Graphite Bio Inc |
2 Q |
- |
- |
20.1 |
0.28 |
Tcr2 Therapeutics Inc |
1 Q |
- |
- |
2.32 |
0.5 |
Tc Biopharm holdings Plc |
4 Q |
- |
- |
0.71 |
- |
Palisade Bio Inc |
2 Q |
- |
- |
7.02 |
0.12 |
Argenx se |
4 Q |
- |
- |
2.65 |
0.11 |
Sana Biotechnology Inc |
2 Q |
- |
- |
2.91 |
0.99 |
Molecular Partners Ag |
4 Q |
- |
- |
1.53 |
0.17 |
Entera Bio Ltd |
1 Q |
- |
- |
7.16 |
0.15 |
Phoenix Biotech Acquisition Corp |
2 Q |
- |
- |
0.02 |
- |
Cannabis Global Inc. |
2 Q |
- |
0.1 |
0.04 |
0.17 |
Apeiron Capital Investment Corp |
1 Q |
- |
- |
0.07 |
- |
Mink Therapeutics Inc |
2 Q |
- |
- |
0.93 |
- |
Clarus Therapeutics Holdings Inc. |
2 Q |
- |
- |
0.31 |
- |
Cognition Therapeutics inc |
2 Q |
- |
- |
4.7 |
0.28 |
Renovacor Inc |
3 Q |
- |
- |
6.37 |
0.15 |
Surrozen Inc |
2 Q |
- |
- |
8.28 |
0.16 |
Exscientia Plc |
4 Q |
- |
- |
0.26 |
0.05 |
Gamida Cell Ltd |
2 Q |
- |
- |
2.61 |
- |
Aceragen Inc |
1 Q |
- |
0.28 |
0.12 |
2.48 |
Cardiol Therapeutics inc |
4 Q |
- |
- |
6.07 |
0.19 |
Ladrx Corporation |
2 Q |
- |
- |
1.64 |
1.24 |
Scilex Holding Company |
2 Q |
- |
1.53 |
0.33 |
12.1 |
Coeptis Therapeutics Holdings Inc |
2 Q |
- |
0.8 |
1.29 |
1.86 |
Fresh Tracks Therapeutics Inc |
2 Q |
- |
- |
4.84 |
0.23 |
Prime Medicine Inc |
2 Q |
- |
- |
7.01 |
0.17 |
Pluri Inc |
2 Q |
- |
1.54 |
0.95 |
1.94 |
Vigil Neuroscience Inc |
2 Q |
- |
- |
18.39 |
0.14 |
Arcellx Inc |
2 Q |
- |
- |
3.24 |
1.12 |
Vectivbio Holding Ag |
4 Q |
- |
- |
8.95 |
0.18 |
Humacyte Inc |
2 Q |
- |
0.59 |
10.06 |
1.75 |
First Light Acquisition Group Inc |
2 Q |
- |
- |
0.08 |
- |
Tradeup Acquisition Corp |
2 Q |
- |
- |
- |
- |
Bioatla Inc |
2 Q |
- |
- |
5.01 |
0.26 |
Finch Therapeutics Group Inc |
2 Q |
- |
- |
3.56 |
0.34 |
Recursion Pharmaceuticals Inc |
2 Q |
- |
0 |
3.56 |
0.42 |
Vor Biopharma Inc |
2 Q |
- |
- |
14.7 |
0.21 |
Innate Pharma Sa |
4 Q |
- |
- |
2.04 |
0.93 |
Greenlight Biosciences Holdings Pbc |
1 Q |
- |
0.63 |
1.04 |
4.18 |
Freeline Therapeutics Holdings Plc |
4 Q |
- |
- |
1.53 |
0.79 |
Evaxion Biotech A |
4 Q |
- |
0.95 |
1.78 |
1.65 |
4d Molecular Therapeutics Inc |
2 Q |
- |
- |
22.57 |
0.08 |
Graf Acquisition Corp Iv |
2 Q |
- |
- |
0.01 |
- |
Compass Therapeutics Inc |
2 Q |
- |
- |
17.4 |
0.06 |
Talaris Therapeutics Inc |
2 Q |
- |
- |
15.02 |
0.07 |
Monte Rosa Therapeutics Inc |
2 Q |
- |
- |
10.64 |
0.3 |
Opthea Limited |
2 Q |
- |
- |
5.07 |
- |
Icosavax Inc |
2 Q |
- |
- |
16.45 |
0.09 |
In8bio Inc |
2 Q |
- |
- |
4.49 |
0.1 |
Avalon Globocare Corp |
2 Q |
- |
0.1 |
- |
0.68 |
Caribou Biosciences Inc |
2 Q |
- |
- |
7.54 |
0.3 |
Tscan Therapeutics Inc |
2 Q |
- |
0.16 |
5.95 |
0.36 |
Acumen Pharmaceuticals Inc |
2 Q |
- |
- |
7.93 |
0.05 |
Armata Pharmaceuticals Inc |
2 Q |
- |
1.38 |
0.24 |
3.53 |
Elevation Oncology inc |
2 Q |
- |
0.41 |
12.82 |
0.53 |
Miromatrix Medical inc |
3 Q |
- |
0.01 |
7.77 |
0.24 |
Spk Acquisition Corp |
3 Q |
- |
- |
4.64 |
- |
Cyclo Therapeutics Inc |
2 Q |
- |
- |
0.14 |
- |
Atyr Pharma Inc |
2 Q |
- |
- |
8.78 |
0.12 |
Revolution Medicines Inc |
2 Q |
- |
- |
11.65 |
0.03 |
Enzon Pharmaceuticals inc |
2 Q |
- |
- |
114.75 |
0.15 |
Apogee Therapeutics inc |
2 Q |
- |
- |
7.1 |
- |
Abcam Plc |
4 Q |
- |
- |
- |
- |
Eiger Biopharmaceuticals Inc |
2 Q |
- |
2.64 |
1.38 |
3.71 |
Editas Medicine inc |
2 Q |
- |
- |
7.92 |
0.36 |
Rubius Therapeutics Inc |
4 Q |
- |
- |
1.87 |
0.08 |
Kymera Therapeutics Inc |
2 Q |
- |
- |
6.73 |
0.06 |
Ikena Oncology Inc |
2 Q |
- |
- |
13.1 |
0.1 |
Cel sci Corporation |
2 Q |
- |
- |
1.41 |
1.19 |
Sqz Biotechnologies Company |
2 Q |
- |
- |
3.71 |
0.31 |
Codiak Biosciences Inc |
3 Q |
- |
- |
3.58 |
0.58 |
Hillevax Inc |
2 Q |
- |
0.11 |
13.31 |
0.31 |
Turnstone Biologics Corp |
2 Q |
- |
- |
2.64 |
- |
Outlook Therapeutics Inc |
2 Q |
- |
- |
0.68 |
- |
Microbot Medical Inc |
2 Q |
- |
- |
7.53 |
0.13 |
Zura Bio Limited |
2 Q |
- |
- |
5.66 |
0.31 |
Genethera Inc |
4 Q |
- |
- |
- |
- |
Green Planet Bioengineering Co Ltd |
2 Q |
- |
- |
- |
- |
Intensity Therapeutics Inc |
2 Q |
- |
- |
0.04 |
0.2 |
Genenta Science S p a |
4 Q |
- |
- |
13.65 |
0.05 |
Genocea Biosciences Inc |
1 Q |
- |
0.38 |
1.12 |
0.82 |
Oyster Point Pharma Inc |
3 Q |
- |
- |
2.36 |
- |
Champions Oncology Inc |
2 Q |
- |
- |
0.24 |
4.47 |
Crispr Therapeutics Ag |
2 Q |
- |
- |
13.31 |
0.21 |
Anavex Life Sciences Corp |
2 Q |
- |
- |
- |
0.14 |
Atara Biotherapeutics Inc |
2 Q |
- |
- |
2.06 |
32.06 |
Peak Bio Inc |
2 Q |
- |
- |
0.01 |
- |
Century Therapeutics inc |
2 Q |
- |
- |
8.16 |
0.69 |
Aim Immunotech Inc |
2 Q |
- |
- |
9.84 |
0.09 |
Aura Biosciences Inc |
2 Q |
- |
- |
18.22 |
0.16 |
Applied Genetic Technologies Corporation |
3 Q |
- |
0.54 |
1.29 |
0.9 |
Agenus Inc |
2 Q |
- |
- |
0.77 |
- |
Adverum Biotechnologies Inc |
2 Q |
- |
- |
3.18 |
0.34 |
Sophia Genetics Sa |
4 Q |
- |
- |
6.02 |
0.08 |
Biocardia Inc |
2 Q |
- |
- |
1.19 |
2.91 |
Brainstorm Cell Therapeutics inc |
2 Q |
- |
- |
0.1 |
- |
Curis Inc |
2 Q |
- |
- |
6.56 |
2.17 |
Prokidney Corp |
2 Q |
- |
- |
18.21 |
- |
Forma Therapeutics Holdings Inc. |
2 Q |
- |
- |
11.83 |
0.07 |
Compugen Ltd |
4 Q |
- |
- |
7.02 |
0.2 |
Vaxcyte Inc |
2 Q |
- |
- |
21.37 |
0.03 |
Cidara Therapeutics Inc |
2 Q |
- |
- |
1.61 |
3.41 |
Axcella Health Inc |
2 Q |
- |
- |
0.77 |
- |
Organicell Regenerative Medicine Inc |
2 Q |
- |
- |
0.2 |
- |
Fusion Pharmaceuticals Inc |
2 Q |
- |
0.17 |
11.59 |
0.3 |
Bluebird Bio Inc |
2 Q |
- |
- |
1.82 |
0.23 |
Adaptimmune Therapeutics Plc |
2 Q |
- |
- |
2.69 |
1.71 |
La Jolla Pharmaceutical Company |
2 Q |
- |
- |
2.95 |
- |
Allogene Therapeutics Inc |
2 Q |
- |
- |
8.99 |
0.24 |
Eloxx Pharmaceuticals Inc |
2 Q |
- |
- |
0.2 |
- |
Allena Pharmaceuticals Inc. |
2 Q |
- |
1.31 |
0.63 |
2.29 |
Springworks Therapeutics Inc |
2 Q |
- |
- |
11.37 |
0.15 |
Krystal Biotech Inc |
2 Q |
- |
- |
19.98 |
0.05 |
Qrons Inc |
2 Q |
- |
- |
0.01 |
- |
Vir Biotechnology Inc |
2 Q |
- |
- |
8.19 |
0.24 |
Biomx Inc |
2 Q |
- |
0.9 |
2.55 |
1.59 |
Iovance Biotherapeutics inc |
2 Q |
- |
0 |
2.83 |
0.29 |
Cabaletta Bio Inc |
2 Q |
- |
- |
20.79 |
0.06 |
Xtant Medical Holdings Inc |
2 Q |
- |
0.55 |
0.24 |
1.11 |
Avrobio Inc |
2 Q |
- |
- |
10.69 |
0.08 |
Solid Biosciences Inc |
2 Q |
- |
- |
10.1 |
0.25 |
Kodiak Sciences Inc |
2 Q |
- |
- |
5.1 |
0.74 |
Sutro Biopharma Inc |
2 Q |
- |
0.07 |
5.34 |
2 |
Jasper Therapeutics Inc |
2 Q |
- |
- |
12.91 |
0.13 |
Mesoblast Ltd |
2 Q |
- |
0.2 |
0.65 |
0.33 |
Fennec Pharmaceuticals Inc |
2 Q |
- |
- |
3.96 |
- |
Gritstone Bio Inc |
2 Q |
- |
0.27 |
5.18 |
0.48 |
Meiragtx Holdings Plc |
2 Q |
- |
0.58 |
1.29 |
1.51 |
Aptose Biosciences Inc |
2 Q |
- |
- |
1.95 |
0.9 |
Surface Oncology Inc |
2 Q |
- |
- |
3.34 |
0.34 |
Sab Biotherapeutics Inc |
2 Q |
- |
0.03 |
0.71 |
0.8 |
Windtree Therapeutics Inc |
2 Q |
- |
0.06 |
3.02 |
2.46 |
Voyager Therapeutics Inc |
2 Q |
- |
- |
6.01 |
0.17 |
Vericel Corporation |
2 Q |
- |
- |
2.75 |
0.56 |
Pharmacyte Biotech Inc |
2 Q |
- |
- |
49.18 |
0.48 |
Protalix Biotherapeutics inc |
2 Q |
- |
0.52 |
2.09 |
1.15 |
Point Of Care Nano technology Inc |
1 Q |
- |
- |
- |
- |
Old Ayala Inc |
4 Q |
- |
- |
0.32 |
- |
Organovo Holdings Inc |
2 Q |
- |
- |
6.08 |
0.25 |
Cardiff Oncology inc |
1 Q |
- |
- |
19.41 |
0.05 |
Mymetics Corporation |
2 Q |
- |
- |
- |
- |
Ambrx Biopharma Inc |
2 Q |
- |
- |
12.93 |
0.12 |
Sorrento Therapeutics Inc |
2 Q |
- |
- |
0.3 |
- |
Aziyo Biologics inc |
2 Q |
- |
- |
0.22 |
- |
Tenaya Therapeutics Inc |
2 Q |
- |
- |
6.33 |
0.16 |
Candel Therapeutics Inc |
2 Q |
- |
0.68 |
6.36 |
0.89 |
Titan Pharmaceuticals Inc |
2 Q |
- |
- |
0.06 |
- |
Instil Bio Inc |
2 Q |
- |
0.27 |
10.98 |
0.32 |
Tracon Pharmaceuticals Inc |
2 Q |
- |
- |
0.06 |
- |
Quince Therapeutics Inc |
2 Q |
- |
- |
33.26 |
0.02 |
Senti Biosciences Inc |
2 Q |
- |
- |
5.72 |
0.47 |
Immunovant Inc |
2 Q |
- |
- |
6.42 |
0.17 |
Invivyd Inc |
2 Q |
- |
- |
9.18 |
0.11 |
Mosaic Immunoengineering Inc |
2 Q |
- |
- |
0.08 |
- |
Autolus Therapeutics Plc |
4 Q |
- |
- |
8.25 |
0.49 |
Achilles Therapeutics Plc |
4 Q |
- |
- |
9.63 |
0 |
Logicbio Therapeutics Inc |
3 Q |
- |
0.21 |
1.87 |
0.28 |